CHD4 ensures stem cell lineage fidelity during skeletal muscle regeneration

Regeneration of skeletal muscle requires resident stem cells called satellite cells. Here, we report that the chromatin remodeler CHD4, a member of the nucleosome remodeling and deacetylase (NuRD) repressive complex, is essential for the expansion and regenerative functions of satellite cells. We sh...

Descripción completa

Detalles Bibliográficos
Autores: Sreenivasan, Krishnamoorthy, Rodríguez de la Rosa, Alejandra, Kim, Johnny, Mesquita, Diana, Segalés Dalmau, Jessica, Gómez del Arco, Pablo, Espejo, Isabel, Ianni, Alessandro, Di Croce, Luciano, Relaix, Frederic, Redondo, Juan Miguel, Braun, Thomas, Serrano Sánchez, Antonio L., Perdiguero, Eusebio, 1968-, Muñoz Cánoves, Pura, 1962-
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2021
País:España
Institución:Universitat Pompeu Fabra
Repositorio:Repositorio Digital de la UPF
OAI Identifier:oai:repositori.upf.edu:10230/48691
Acceso en línea:http://hdl.handle.net/10230/48691
http://dx.doi.org/10.1016/j.stemcr.2021.07.022
Access Level:acceso abierto
Palabra clave:Chd4
NuRD
Lineage maintenance
Muscle stem cell
Regeneration
Satellite cells
Skeletal muscle
Descripción
Sumario:Regeneration of skeletal muscle requires resident stem cells called satellite cells. Here, we report that the chromatin remodeler CHD4, a member of the nucleosome remodeling and deacetylase (NuRD) repressive complex, is essential for the expansion and regenerative functions of satellite cells. We show that conditional deletion of the Chd4 gene in satellite cells results in failure to regenerate muscle after injury. This defect is principally associated with increased stem cell plasticity and lineage infidelity during the expansion of satellite cells, caused by de-repression of non-muscle-cell lineage genes in the absence of Chd4. Thus, CHD4 ensures that a transcriptional program that safeguards satellite cell identity during muscle regeneration is maintained. Given the therapeutic potential of muscle stem cells in diverse neuromuscular pathologies, CHD4 constitutes an attractive target for satellite cell-based therapies.